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ABSTRAK 
 
Kanser ovari dan uterus merangkumi 5.0% dan 3.6% keseluruhan kes kanser wanita 
Malaysia. Kanser ovari (OC) merupakan ketumbuhan ginekologi pembawa maut yang 
utama kerana tiada terdapat gejala di peringkat awal sehingga kanser telah merebak. 
Ultrasonografi membenarkan pengesanan awal memberi peluang bagi pakar perubatan 
menyediakan rawatan dan kaunseling untuk wanita tersebut. Sebagai teras untuk saringan 
selektif, satu kajian telah dijalankan merangkumi 517 wanita bandar berusia 45+ tahun 
bebas penyakit, bukan pengguna HRT dan masih mempunyai uterus. Normogram ovari, 
uterus dan endometrium yang diperolehi daripada  pemeriksaan ultrasound garisdasar 
dibentang.  Sampel kajian terdiri daripada 58% dan 42% wanita pra dan pos-menopos 
dengan umur purata 51.27 ± 5.35 tahun. Lebih dua pertiga terdiri dari kaum Cina, diikuti 
oleh Melayu dan India. Kajian menunjukkan saiz purata jasad uterus dan ukuran 
endometrium (ET) adalah 7.21 ± 1.67x4.36 ± 1.30cm and 6.36 ± 3.73mm masing-masing. 
Saiz uterus wanita pre-menopos lebih besar berbanding pos-menopos (p<0.0005) dan 
atrofi uterus berlaku berikutan umur dan menopos. Ukuran ET juga lebih tebal pada wanita 
pre berbanding pos-menopos (p<0.0005), semakin tipis mengikut usia. Wanita pada awal 
pos-menopos menunjukkan ET <5mm, mencapai 2mm pada wanita berusia >70 tahun. 
Dengan demikian, tetapan normal klinikal kesemua wanita pos-menopos tanpa mengira 
kaum ditetapkan pada ET<5mm. Hampir seperlima wanita (18.9%) didapati mempunyai 
fibroid uterus, sebanyak sesuku (25.0%) semasa pre berbanding 10% pos-menopos 
(p<0.0005). Purata isipadu ovari (OV) kanan dan kiri masing-masing adalah 5.48 ± 
7.85cm3 and 5.80 ± 16.78cm3. Terdapat pengurangan OV mengikut usia dan menopos, 
daripada  7cm3 pada usia 45-49 tahun kepada <1.5cm3 pada 70 tahun, menghasilkan 
tetapan normal klinikal wanita Malaysia pre dan pos-menopos pada OV <7.5cm3 and 
<3.5cm3. Sista ovari tidak ada bahaya dijumpa pada 2.9% dengan saiz purata 65.14 ± 
88.22cm3. Sebagai kesimpulan, normogram ET dan OV harus disediakan bagi populasi 
Malaysia untuk memudahkan saringan kanser ginekologi. 
 
Kata kunci: perimenopos, ukuran endometrium, saiz uterus, isipadu ovari 
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ABSTRACTS 
 
Cancers of the ovary and corpus uteri afflict 5% and 3.6% Malaysian women respectively. 
Ovarian cancer (OC) remained the deadliest gynaecological malignancy in 
perimenopausal women mainly due to the lack of symptoms until the disease had spread. 
Ultrasonography could provide a preliminary screening allowing the clinician to tailor 
subsequent management and counselling for these women.  To support the basis for 
selective screening, a study on 517 urban disease free women aged 45 years and above, 
uterus-intact, non-users of HRT was undertaken. This study presented normograms of 
ovary, uterus and endometrium derived from entry ultrasound assessment. The sample 
comprised of 58.0% premenopaused and 42.0% postmenopaused women with an average 
age of 51.27±5.35 years old. Over two thirds were Chinese followed by Malays and 
Indians. The findings indicated that the average uterine size and endometrial thickness 
(ET) was 7.21±1.67x4.36±1.30cm and 6.36±3.73mm respectively. Premenopausal women 
had larger uterus compared to those postmenopaused (p<0.0005) and atrophy of the 
uterus with age and menopause was demonstrable regardless of ethnicity. Likewise, mean 
ET in the premenopaused was thicker than the postmenopaused (p<0.0005), showing a 
gradual decrease with age. Early postmenopausal women demonstrated ET of <5mm, 
eventually reaching 2mm in women >70 years old. From these findings, a cut-off of 
<5.0mm was considered clinically acceptable in normal postmenopaused regardless of 
ethnicity. Nearly one fifth (18.9%) had uterine fibroids, a quarter (25%) in premenopausal 
women as compared to 10% postmenopaused (p<0.0005). The mean right and left ovarian 
volume (OV) was 5.48±7.85cm3 and 5.80±16.78cm3 respectively. There was a gradual 
decline in OV with age and menopause from about 7cm3 at age 45-49 years to less than 
1.5cm3 at 70 years giving a clinical norm OV of <7.5cm3 and <3.5cm3 respectively in pre 
and postmenopausal Malaysian women. Benign ovarian cysts seen in 2.9% had a mean 
size of 65.14±88.22cm3. In conclusion, ET and OV normograms should be made available 
for the Malaysian population to facilitate screening for gynaecological malignancies.  
 
Keywords:  perimenopause, endometrial measurement, uterine size, ovarian volume 
 
 
 
INTRODUCTION 
 
In healthy life expectancy studies, women 
can expect to spend more years of their 
lives with functional limitation than men, 
both in developed and developing 
countries. With increasing gender 
difference in life expectancy, data at hand 
is insufficient to assess the extent of 
disability of older women in developing 
countries. In developed countries, studies 
showed that the prevalence of disability is 
less than 5% at 60-64 years, less than 10% 
at 70-74% and above 20% after 85 years. 
With more women reaching beyond 80  
 
years of life, there is concern on the quality 
of their extended lives in the 21st century 
[United Nations Statistic Division 2000]. 
 With the majority of women between 45 
to 60 years being apparently well, it is 
opportune to counsel them at this juncture 
to undergo a general medical audit to 
detect and correct any underlying disease 
early. Currently in Malaysia, this subgroup 
(female) above 45 years comprised 10% of 
the population or about 1.25 million [Dept 
of Statistics 2002]. The perimenopause 
presented a challenge to the clinical 
practitioner as it offered opportunities for 
identification of risk factors for future 
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diseases, indicators for the early presence 
of established disease with subsequent 
enhancement of life quality and care for 
women in the later years [Lobo 2004]. 
 Women between the ages of 40-59 have 
a 1 in 11 chance of developing some type 
of invasive cancers. In comparison, women 
from ages 1-39 have a 1 in 51 chance of 
being diagnosed with cancer [Givens and 
Ling 2003]. The most frequent cancers in 
Malaysian women were cancers of the 
breast, cervix, colon, ovary, leukaemias 
and lung. Cancers of ovary and corpus 
uteri, respectively made up 5% and 3.6% 
of all cancer cases [Looi et al 2004]. 
 Endometrial cancer (EC) accounted for 
3.8% of all cancers in women worldwide. 
EC is one of the commonest malignancies 
seen in 1-25% of women with unexpected 
postmenopausal bleeding, and caused 
fewer deaths compared to cancer of other 
reproductive organs. Almost 90% of 
women above 50 years old had abnormal 
bleeding as the commonest presenting 
symptom [Goldstein et al 2002; Parkin 
1998]. Prior to 1982, diagnostic evaluation 
was routinely by diagnostic dilatation and 
curettage. Nowadays, transvaginal sono-
graphy is becoming an increasingly popular 
tool for endometrial assessment with 
similar false positive rates as endometrial 
sampling in cancer detection. During ultra-
sonography, the image of the endometrium 
showing thickened and heterogeneous 
areas was a predictive factor for 
endometrial malignancy [Gull et al 2003]. 
 The overall five year survival rate was 
70-80% in western countries, ranging from 
90% for stage 1 patients to 20% for stage 
4. The incidence rate rose steadily 5 to 10 
years before menopause, peaked at 65-70 
years and thereafter declined [Parkin 
1998]. The menopausal transition or 
perimenopause was distinguished as a 
period of elevated serum estrogen and low 
levels of progesterone whereby a possible 
“window of risks” existed for development 
of EC. Studies have shown that prolonged 
inter-menstrual period, common in peri- 
 
menopause lead to sustained E2 and ir-
regular progesterone levels [Hale et al 
2002].  
 Ovarian cancer (OC) remained the 
deadliest of all gynaecological malign-
nancies. In the United Kingdom, it 
accounted for nearly 6% of all deaths from 
cancer in females causing more deaths in 
women than for all other gynaecological 
malignancies combined. In United States, 
OC affected 1 in 56 women and caused 
14,500 deaths annually. It was the fourth 
leading cause of cancer death in 
perimenopausal women, mainly due to the 
lack of symptoms in affected patients until 
the disease had spread. With the lack of 
early symptoms, 65-75% of cases 
presented at an advanced stage of the 
disease [Lacey et al 2002; DePriest & 
DeSimone 2003]. The overall five year 
relative survival rate was 28%, but the five 
year survival rate for stages III and IV 
combined was a dismal 10%. A five year 
survival rate greater than 90% may be 
achieved in a small minority when the 
disease was confined to the ovary at 
diagnosis [Austoker 1994].  
 Sonographic detection of abnormal 
postmenopausal ovarian volume or 
demonstration of deviation from the norm 
could assist the clinician in diagnosing 
early ovarian neoplasia. Currently, pelvic 
ultrasonography visualise and characterise 
adnexal masses with greater sensitivity 
and specificity than clinical palpation alone. 
Transvaginal sonography was recom-
mended as the principal technique for final 
assessment of whether a subject should be 
referred for surgical investigations 
[DePriest et al 1997; Collins et al 1998].  
 To support the basis of selective 
screening, a study on disease free urban 
midlife women, non-users of HRT with 
intact uterus aged 45 years old and above 
was undertaken to provide normograms of 
ovarian volume, uterine size and 
endometrial thickness. The findings would 
hopefully provide health indices relevant to 
the local community. 
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MATERIALS AND METHODS 
 
Data for this study was obtained from entry 
assessment of subjects who participated in 
a lifestyle intervention program. Briefly, 
healthy women aged 45 years and above 
with intact uterus, non HRT users were 
recruited from November 1999 to October 
2002 via flyers distributed to the residential 
areas around the hospital including 
subjects from other areas who responded 
after being informed by friends.  
 After an initial screening of 745 women 
by telephone, 522 subjects were accepted 
into the study. Exclusion criteria included 
pregnancy, immigrants, those on treatment 
for hypertension, diabetes mellitus, 
hyperlipidaemia and chronic illnesses. 
Those with secondary causes of 
osteoporosis such as a thyroid/endocrine 
condition e.g. Cushing’s disease, hype-
rthyroidism, hyperparathyroidism, mal-
absorption, hypogonadism, and prolonged 
immobilisation were also excluded. Five 
women were later excluded for surgically 
induced menopause leaving only 517 
subjects. The study protocol was approved 
by the hospital ethics committee as part of 
a Masters of O&G study thesis [Nur Azurah 
2003]. 
 All subjects gave a written informed 
consent before participation in the study. 
Recruits were interviewed for medical 
history and examined by a designated 
physician. Height and weight were 
measured to the nearest 0.1 unit with a 
balance beam weighing machine and 
stadiometer [Health-O-Meter, USA]. Infor-
mation acquired by questionnaires included 
personal characteristics and lifestyle. All 
activities were carried out in the general 
gynaecology clinic by trained personnel.  
 Pelvic ultrasound was performed 
transvaginally (TVS) by qualified sono-
graphers using a 5.0 MHz transvaginal 
probe [Toshiba-Tosbe SSH140A, Tokyo, 
Japan]. Measurements of endometrium, 
uterus and ovaries were taken. Uterus and 
ovaries were measured along the major 
and minor axes in the transverse and 
longitudinal planes. Images and thickness 
of the endometrium were measured along 
with endometrial heterogenicity as a 
predictive factor for endometrial malign-
nancy. 
 The prolate ellipsoid formula (width × 
height × thickness × 0.523) was used to 
calculate the ovarian volume (OV) and/or 
cyst. TVS results were deemed abnormal/ 
positive if premenopausal OV was >20cm3; 
postmenopausal OV >10cm3 respectively 
and cyst volume >10cm3. The presence of 
structures such as solid area or papillary 
projection extending into the cavity of a 
cystic ovarian tumour of any size; or any 
mixed (solid/cystic) component within a 
cystic ovarian tumour suggesting malign-
nancy was noted.  
 Only unambiguous ultrasound measure-
ments were taken into consideration. Data 
were analysed using SPSS for Windows 
version 11.0 software. Continuous varia-
bles were expressed as mean and 
standard deviation, and compared by the 
Student’s t test. Categorical data were 
compared using the Chi-squared test and 
relationships with Pearson correlation 
where appropriate. The differences were 
considered significant if p<0.05. 
 
RESULTS 
  
Subject characteristics 
 
The study sample comprised of 300 
(58.0%) premenopaused and 217 (42.0%) 
postmenopaused women, similarly 
distributed between the major ethnic 
groups [Table 1]. Over two thirds were 
Chinese followed by Malays and Indians, 
reflecting an urban distribution as opposed 
to the general population whereby Malays 
were the major ethnic entity. The average 
age of participants was 51.27±5.35 years 
old. 
 The mean and median age of 
menopause was 49.97±2.90 years and 
50.00 years respectively with no significant 
difference between the ethnic groups. The 
postmenopausal group, aged 55.53±5.27 
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years was 7.4 years older than the 
premenopausal group, 48.14±2.67 years 
(p<0.0005). Malays were the youngest, 
followed by Chinese, Indians and others 
with respective mean age of 50.14±4.33, 
51.51±5.53, 54.47±7.83 and 57.00±10.53, 
a significant difference (p=0.039).  
 The average and median age of 
menarche was 13.57±1.73 and 13.00 years 
old. Indians reached menarche at 
12.55±1.62 years; earlier than Malays, 
Chinese and others with a respective mean 
of 13.36±1.32, 13.72±1.87 and 13.20±0.84 
years (p<0.005). All other reproductive and 
demographic characteristics were not 
significantly different between ethnic 
groups or menopausal status. 
 The mean height, weight and the body 
mass index (BMI) of the sample population 
was 1.55±0.05cm, 59.41±9.50kg and 
24.64±3.89kg/m2 respectively. The pre-
menopausal group was similar in weight, 
height and BMI to the post-menopausal 
group. Malays were the heaviest, 
62.39±10.00kg with significantly higher 
BMI, 26.15±4.30kg/m2, compared to the 
others (both p<0.0005). Weight and BMI of 
Chinese, Indians and other races were 
58.30±9.14kg, 58.03±7.75kg and 
57.20±9.76; 24.08±3.60kg/m2, 23.98±2.83 
kg/m2 and 23.61±2.40kg/m2 respectively. 
Overall, 56.3% had BMI between 18.5 to 
<25 kg/m2, 32% were overweight and 8.6% 
obese. 
 
Uterine size 
 
The average uterine size for the sample 
population was 7.21±1.67 x 4.36±1.30 cm. 
Premenopausal women had significantly 
larger uterus compared to postmeno-
paused women (p<0.0005). There was no 
significant difference in uterine measure-
ments between the three major ethnic 
groups and atrophy of the uterus with 
menopause was demonstrated regardless 
of ethnicity [Table 2].  
 Nearly a fifth (18.9%) of the sample 
population had fibromyoma, most being 
detected from ultrasonography as 
intramural and posterior. A quarter (25%) 
of premenopausal women had uterine 
fibroids compared to 10% post-
menopaused which was statistically 
significant (p<0.0005). There was no signi- 
ficant difference observed in the size of the 
fibroids and prevalence within the three 
ethnic groups [Table 3]. 
 
 
Table 1 : Sociodemographics variables 
 
N=517 N (%) or 
mean ± sd 
Ethnic distribution  
Malay 143 (27.7) 
Chinese 347 (67.1) 
Indian 22 (4.3) 
Others 5 (1.0) 
Sociodemographics  
Age (yrs) 51.27±5.35 
Age of menarche (yrs) 13.57±1.73 
Menopausal age (yrs) 49.97±2.90 
Income (RM) 3311±3141 
Education$   
No formal schooling 21 (4.1) 
Primary level 113 (21.9) 
Secondary level  278 (53.8) 
College/tertiary level 104 (20.1) 
Marital status$  
Married 401 (77.6) 
Widowed 47 (9.1) 
Never married/divorced 68 (13.2) 
Reproductive history  
Post-menopausal 217 (42.0) 
Breastfed (n=449) 299 (66.6) 
Ever user of OCP 197 (38.1) 
Parity (n=450) 3.28±1.38 
Regular menses (before age 
35 yrs) 
456 (88.2) 
Days of menstrual cycle 27.93±2.95 
Breastfeeding duration (month) 11.14±24.60 
OCP duration (month) 19.29±42.83 
Lifestyle  
Never smoke 501 (96.9) 
Never drink alcohol 466 (90.1) 
Anthropometry  
Weight (kg) 59.41±9.50 
Height (m) 1.55±0.05 
Body mass index (kg/m2) 24.64±3.89 
$ one subject did not report these variables  
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Table 2 : Uterine measurements by menopausal status and ethnicity 
 
Uterine measurements All women Malays Chinese Indians Others 
 (cm, mean±sd) 
All N=417 N=90 N=308 N=14 N=5 
Uterine length  7.21±1.67 7.37±1.49 7.17±1.73 7.28±1.68 6.60±1.23 
Uterine width  4.36±1.30 4.47±1.18 4.34±1.35 4.29±1.08 3.80±1.09 
Premenopause* N=236 N=56 N=169 N=8 N=3 
Uterine length  8.08±1.30 8.09±1.18 8.10±1.32 7.95±1.78 7.27±1.16 
Uterine width  4.99±1.09 5.02±1.02 4.99±1.12 4.76±1.07 4.50±0.70 
Postmenopause  N=181 N=34 N=139 N=6 N=2 
Uterine length  6.08±1.39 6.18±1.15 6.05±1.47 6.38±1.11 5.60±0.14 
Uterine width  3.54±1.08 3.55±0.77 3.54±1.16 3.65±0.77 2.75±0.35 
*p<0.0005 (menopausal status)     
 
 
 
Table 3 : Prevalence and size of fibromyoma by menopausal status and ethnicity 
 
All women Malays Chinese Indians Others N 
417 90 308 14 5 
Prevalence % (n) 
Fibromyoma present  18.9 (79) 15.5 (13) 19.8 (61) 28.6 (4) 20.0 (1) 
Premenopause* 75.9 (60) 76.9 (10) 73.8 (45) 100.0 (4) 100.0 (5) 
Postmenopause 24.1 (19) 23.1 (3) 26.2 (16) - - 
Fibroid measurements  (cm, mean±sd) 
Lengthwise  3.17±1.31 3.07±1.15 3.23±1.39 2.75±0.55 2.50 
Width  3.48±1.42 3.63±1.50 3.49±1.46 3.00±0.51 2.60 
Premenopause      
Lengthwise  3.29±1.28 3.48±0.90 3.32±1.40 2.75±0.55 2.50 
Width 3.57±1.43 4.13±1.27 3.51±1.51 3.00±0.51 2.60 
Postmenopause      
Lengthwise  2.78±1.39 1.70±0.79 2.99±1.40 - - 
Width 3.21±1.40 1.97±0.95 3.44±1.37 - - 
*p<0.0005 (menopausal status)     
 
 
 
 A normogram drawn of pre and 
postmenopausal women free of fibroids 
showed a gradual decrease in uterine 
measurements with age. Postmenopausal 
women demonstrated much smaller uterine 
measurements than premenopaused wo-
men [Figure 1]. Length and width of the 
uterus was positively correlated to weight, 
height, BMI, education and income but 
negatively correlated to current age, age of 
menarche or being postmenopaused. The 
main predictors of uterine length (adjusted 
R2=0.380, p<0.0005) from multiple 
regression analysis were current age 
(ß=0.140, p<0.009), menopausal status  
 
 
(ß=0.496, p<0.0005) and income (ß=0.081, 
p<0.043). Uterine width also showed 
similar associations. 
 The occurrence of fibroids was 
negatively correlated to current age, age of 
menarche, and postmenopausal state but 
the only significant predictor was meno-
pausal state (ß=0.189, p<0.043; R2=0.033, 
p<0.0005). 
 
Endometrial thickness (ET) 
 
Mean ET for the sample was 6.36±3.73mm 
[Table 4]. Premenopausal ET was 
significantly thicker than the post- 
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Figure 1: Uterine size (normogram) in pre and postmenopausal women by age. The two upper lines represent 
uterine length while the two lower lines were the uterine widths. Only uterine measurements from women without 
fibroids were included in plotting the normogram. Solid and dotted lines denote mean values in postmeno-pausal 
and premenopausal women res- pectively. There were a total of 176 pre-menopaused subjects divided into age 
category 45-49.9 (129), 50-54.9 (43) and 55-59.9 (4). Number of postmenopaused subjects in each age category 
was 45-49.9 (14), 50-54.9 (60), 55-59.9 (50), 60-64.9 (24), 65-69.9 (12) and ≥70 (2) for a total of 122. Number in 
parentheses denoted the number of subjects in each age category. 
 
 
 
menopaused group (p< 0.0005). Indian 
women had a comparatively thicker ET 
than other ethnic groups but this is not 
statistically significant. 
 ET showed decreasing thickness with 
age in pre and postmenopausal women. 
Early postmenopausal women demon-
strated ET of less than 5mm, eventually 
reaching 2mm in women of more than 70 
years old. From these findings, a cut-off of 
less than 5.0mm was considered as 
clinically acceptable for normal post-
menopausal ET regardless of ethnicity 
[Figure 2]. Utilising this cut off (less than 
5mm) for postmenopausal women at 55 
years old and above, 16.3% of post-
menopausal women required further invest-
tigation although none of the subjects 
showed endometrial cancer (EC) on  
 
endometrial sampling. 
 ET was positively correlated to weight, 
height, education and income but was 
negatively correlated to current age, age of 
menarche and being postmenopaused. 
Multiple linear regression analysis showed 
the significant predictors to be menopausal 
status (ß=0.373, p<0.0005) and current 
age (ß=0.213, p<0.0005) with adjusted 
R2=0.290 (p<0.0005). 
 
Ovarian volume (OV) 
 
The average right and left ovarian volume 
(OV) was 5.48±7.85cm3 and 
5.80±16.78cm3, being not statistically 
different [Table 5]. A significant difference 
in right ovarian volume (ROV) was 
observed between the three main ethnic 
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Table 4: Endometrial thickness by menopausal status and ethnicity  
 
All Malays Chinese Indians Others Endometrial 
thickness N=417 N=90 N=308 N=14 N=5 
 (mm, mean±sd) 
All women 6.36±3.73 6.78±3.80 6.17±3.70 7.58±4.14 6.52±3.16 
Premenopause* 8.05±3.59 8.00±3.69 7.97±3.58 9.81±3.61 8.70±1.01 
Postmenopause 4.14±2.60 4.78±3.11 3.98±2.46 4.60±2.78 3.25±1.48 
*p<0.0005 (menopausal status)     
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Figure 2: Endometrial thickness (normogram) of pre and postmenopausal women by age. Solid and dotted lines 
represent mean values in postmenopausal and premeno-pausal women respectively (Figure 2). There were a 
total of 176 premenopaused subjects divided into age category 45-49.9 (129), 50-54.9 (43) and 55-59.9 (4). 
Number of postmenopaused subjects in each age category was 45-49.9 (14), 50-54.9 (60), 55-59.9 (50), 60-64.9 
(24), 65-69.9 (12) and ≥70 (2) for a total of 122. Number in parentheses denoted the number of subjects in each 
age category. 
 
 
groups (p<0.005). Premenopausal Indian 
women had larger ROV compared to 
Malays and Chinese due to the presence 
of ovarian cyst with mean LOV being 
similar. In postmenopausal women, ROV 
and LOV were similar between the ethnic 
groups. Postmenopausal ROV was 
significantly smaller than the pre-
menopaused (p<0.0005) but LOV was not  
 
statistically different. 
 Ovarian cysts were seen in 12 women 
i.e. 2.9% of sample with a mean size of 
65.14±88.22cm3 [Table 6]. Cysts were 
slightly larger in postmenopausal women 
than in premenopaused although the 
premenopaused had a higher prevalence. 
The size and prevalence of asymptomatic 
ovarian tumour was not significantly 
  
 73 
Med & Health 2007; 2(1): 66-79  Adeeb N et. al. 
 
Table 5 : Ovarian volume by menopausal status and ethnicity 
 
Ovarian volume All women Malays Chinese Indians Others 
 (cm3, mean±sd) 
All women N=409 N=89 N=302 N=13 N=5 
RO volume*  5.48±7.85 5.51±7.44 5.17±5.90 12.97±27.36 3.68±3.18 
LO volume  5.80±16.78 5.04±5.38 6.07±19.33 5.84±5.92 3.79±3.21 
Premenopause N=236 N=56 N=169 N=8 N=3 
RO volume# $ 7.19±9.18 7.08±8.75 6.68±6.07 19.26±34.12 5.37±3.05 
LO volume  6.64±10.07 6.66±6.21 6.60±11.28 7.721±6.99 5.29±3.64 
Postmenopause  N=173 N=34 N=137 N=6 N=2 
RO volume  3.14±4.66 2.85±2.98 3.26±5.09 2.91±1.75 1.14±0.64 
LO volume   4.65±23.02 2.35±1.37 5.37±26.40 2.84±1.19 1.53±0.46 
*p<0.005 (ethnicity) 
#p<0.002 (ethnicity) 
$p<0.0005 (menopausal status) 
    
 
 
 
 
 
Table 6 : Ovarian cyst prevalence, dimensions and volume by menopausal status and ethnicity ] 
 
All women Malays Chinese Indians N 
409 89 297 13 
Prevalence % (n) 
All  2.9 (12) 2.2 (2) 3.0 (9) 7.7 (1) 
Premenopause  58.3 (7) 50.0 (1) 55.6 (5) 100.0 (1) 
Postmenopause 41.7 (5) 50.0 (1) 44.4 (4) - 
Ovarian cyst volume (cm3, mean±sd) 
All  65.14±88.22 31.38±33.28 66.97±99.74 116.24 
Premenopause  62.35±56.51 54.92 53.05±62.78 116.24 
Postmenopause 69.06±128.76 7.84 84.37±143.33 - 
 
 
 
 
 
different between premenopausal and 
postmenopausal women with no 
differences observed between the ethnic 
groups in this small number [Table 6]. 
A normogram plotted using mea-surement 
from women who were cyst-free, showed a 
gradual decline in pre-menopausal OV 
from about 7cm3 at age 45-49 years to less 
than 4cm3 at age 55-59 years. ROV was 
comparatively larger in older 
premenopausal (>50 years) com-pared to 
younger (≤50 years) pre-menopausal 
women. Among post-menopausal women, 
OV declined from over 3cm3 at age 50-54 
to less than 1.5cm3 at 70 years old. After 
60 years of age, both ROV and LOV 
remained consistent at less than 3cm3 
[Figure 3].  
 Since there was no statistical difference 
in volume between the right and left ovary,  
 
correlation was reported for the largest 
ovary. OV was positively correlated to 
weight and negatively correlated to current 
age, age of menarche, days of menstrual 
cycle and being postmenopaused. The 
only predictor of ROV from multiple linear 
regression analysis was menopausal status 
(ß=0.255, p<0.0005) with adjusted 
R2=0.063 (p<0.0005). Unlike ROV, the 
significant predictors for LOV were age of 
menarche (ß=0.152, p<0.004) and number 
of days in the menstrual cycle (ß=0.107, 
p<0.040) with adjusted R2=0.029 
(p=0.002). Ovarian cyst volume showed 
positive correlation to age of menarche and 
age of 1st childbirth with the age of 1st 
childbirth (ß=0.578, p=0.030) as the only 
predictor with adjusted R2=0.620 (p=0.014) 
in the final model.  
 From this study, a clinically normal OV of 
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Figure 3: Ovarian volume (normogram) of pre and postmenopausal women by age. Solid and dotted lines 
represent mean values in postmenopausal and pre-menopausal women respectively. Premenopausal subjects 
(229) were divided into age category 45-49.9 (167), 50-54.9 (57) and 55-59.9 (5).  Postmenopaused women (168) 
were distributed into age category 45-49.9 (14), 50-54.9 (66), 55-59.9 (52), 60-64.9 (24), 65-69.9 (10) and ≥70 
(2). Number in parentheses denote the number of subjects in each age category. 
 
 
 
<7.5cm3 and <3.5cm3 respectively for pre 
and postmenopausal Malaysian women 
aged 45 and above was unquestionably 
demonstrated. Ovarian tumour was 
suspected when ovaries were larger in size 
than the clinical norm by two standard 
deviations i.e. over 20cm3 for pre-
menopause and 10cm3 for post-
menopaused women. Utilising this cut-off 
index, 3.0% and 3.4% premenopausal and 
postmenopausal women respectively would 
require follow ups. Older postmenopausal 
women aged 55 years old and above 
showed a higher incidence of deviation 
from norm, i.e. 4.5%. Any enlargement in 
the ovaries in the postmenopause was 
considered ominous requiring vigilant 
monitoring. Follow ups showed that except 
for a larger volume, no subject had the 
presence of structures associated with 
malignancies.  
  
DISCUSSION 
 
Uterine size and uterine leiomyomata  
 
Uterine size of women in this study was 
comparable to other reported studies [Merz 
et al 1996]. The size of uterus was 
influenced by the presence of uterine 
fibroids which prevailed in 25 to 77% 
women of various populations [Stewart 
2001]. In a study of 95,061 premenopausal 
nurses, the age-standardised rates of 
ultrasound or hysterectomy confirmed 
diagnoses of uterine fibroids per 1000 
women years were 8.9 among white 
women, 30.6 among black women, 11.0 
among Hispanics and 8.0 among Asians 
with peak incidence ranging from 40-44 
years [Marshall et al 1997]. In comparison, 
19% of all women in this study had 
asymptomatic fibroids, more common in 
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premenopaused (25%) compared to the 
postmenopaused (10%).  This was higher 
than the 4.9% prevalence reported for 164 
women who attended an urban menopause 
clinic in Malaysia [Damodaran et al 2000]. 
In comparison, the reported prevalence in 
Thai women was 45% in the 
premenopaused and 6.3% in post-
menopaused [Jirapinyo et al 1998].  
 Despite the prevalence, very little is 
known about this condition as few studies 
had been carried out probably due to its 
benign nature with few clearly established 
risk factors for fibroids [Baird 2004]. A 
significant positive association was seen 
between its incidence with age, race, body 
mass index, years since last term birth, 
history of infertility and current alcohol 
consumption. Significant inverse asso-
ciation was seen between age at 
menarche, age at first term birth, age at 
first oral contraceptive use and never being 
married [Marshall et al 1997]. In con-
cordance, this study found that fibroids 
were negatively correlated to current age, 
age of menarche, and postmenopausal  
state with the only significant predictor 
being menopause.  
  
Endometrial cancer (EC) 
 
As this study recruited only disease-free, 
non-users of HRT with intact uterus, none 
presented with EC but postmenopausal 
endometrium thickness cut-off of 5mm was 
proposed based on the normogram, similar 
to the consensus made by the Society of 
Radiologists in Ultrasound Consensus 
Conference Statement on Postmenopausal 
bleeding, the recommended cut-off point to 
rule out malignancy in symptomatic 
postmenopausal women [Goldstein et al 
2002] as thin endometrium was found 
almost never to harbour carcinoma [Gull et 
al 2003].  
 In a meta-analysis, when post-meno-
pausal women with EC presented with 
vaginal bleeding, the median ET was found 
to be 3.7 times thicker than those 
unaffected. The detection rate was 96% 
with a 50% false positive rate which in the 
authors’ opinion, still required invasive 
diagnostic testing in order not to miss 4% 
of EC [Tabor et al 2002]. Not much was 
known about EC in Malaysia except it 
being among the ten commonest malign-
nancies [Lim 2002]. 
 Known factors that affected the 
endometrium were obesity, reproductive 
characteristics, certain medical conditions 
and cigarette smoking which may be 
explained partly by their effect on estrogen 
and progesterone [Hale et al 2002]. In this 
study, ET was positively correlated to 
weight, height, education and income. ET 
was negatively correlated to current age, 
age of menarche and being post-meno-
paused. Multiple linear regression analysis 
showed the significant predictors to be 
menopausal status and current age. The 
relationship between ET and variables 
such as obesity and smoking was not 
observed as most of our subjects did not 
smoke (>97%) and few were grossly 
overweight. 
 
Ovarian cancer (OC) 
 
Results from this study showed a decline of 
OV with age in premenopausal and 
postmenopausal women not receiving 
HRT. The sizes of ovaries concurred with 
those from other studies [Opperman et al 
2003; Pavlik et al 2000] and consequently 
similar clinical cut-off values were 
considered applicable to our population. 
Zalel et al [1996] showed an increased OV 
of more than two standard deviations from 
norm for each postmenopausal age were 
highly suggestive of malignancy. This 
deviation from norm was striking in 
malignant tumour (100%) compared to 
benign (86%) with proposed upper limit for 
OV in premenopaused women as 20cm3 
and for postmenopaused as 10cm3 [Merz 
et al 1996]. In expert hands, OV and 
morphologic evaluation of complexity was 
shown to be inexpensive and accurate for 
differentiating benign from malignant 
tumours with sensitivity, specificity, PPV 
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and NPV of 0.981, 0.808, 0.409 and 0.997 
respectively [Ueland et al 2003]. 
 In this sample we did not encounter any 
patient with ovarian malignancy and hence 
could not provide a practical model. 
Ovarian cysts were seen in 2.9% of our 
subjects, slightly more prevalent among 
premenopausal women. Studies had 
shown that persistent lesions could be 
detected in about 3.6% of self referred, 
asymptomatic women at the first 
attendance of ultrasound screening. About 
1.2% of screened subjects would have one 
benign tumour. The prevalence of OC was 
about 0.004%, more prevalent among 
postmenopausal women (over 94% of 
cases occurred in women over 40 years 
old) [Collins et al 1998]. In our experience, 
69% of all ovarian tumours were benign 
with a younger peak age in the 3rd decade 
and most cancers were detected in the 4th 
to 5th decade. Tumours were rare before 
the 2nd decade and 77% were in the 
reproductive age [Thanikasalam et al 
1992]. 
 OV was shown to be associated with 
age, menopausal status, phases of the 
menstrual cycle and hormonal milieu during 
menopausal transition [Merz et al 1996; 
Opperman et al 2003; Giacobbe et al 
2004], variables similarly found in this 
study. Possibly due to the higher presence 
of cyst on the right ovary, the predictors of 
ROV differed from LOV being only 
menopausal status whereas significant 
predictors of LOV were age of menarche 
and days of the menstrual cycle. 
  Data from this study did not reflect the 
general Malaysian population as the 
sample consisted of urban women with a 
Chinese majority instead of the usual 
population ratio. The sampled population 
had higher income, better education and 
access to health care. Nevertheless, this 
obtained data would be useful basis for 
further investigations particularly in high 
risk groups. Obtaining a complete data 
base is essential for delivering appropriate 
preventive services as incomplete data 
may result in inaccurate risk assessment 
resulting in inappropriate interventions.  
 It is known that women with a first degree 
family history of breast cancer (BC) had a 
1.7 fold increased risk of OC; an 
association with reciprocal ramifications.  
An increased risk of 2.2 fold was seen in 
women with a first degree relative affected 
with OC. Corresponding risks of 7.1 to 10.7 
fold were observed for those with two or 
three affected relatives. Screening a 
population for OC with at least one first 
degree affected relative gave a prevalence 
of 3.8/1000 women. Screening women with 
BC/OC diseases gave a prevalence of 
50/1000 [Collins et al 1998]. Thus OV and 
ET normogram should be made available 
for the local population to enable clinicians 
to tailor subsequent management and 
counselling. 
 In summary, the findings showed that the 
uterus atrophy with age and menopause 
regardless of ethnicity. Nearly one fifth of 
all subjects had uterine fibroids, 
significantly more among premenopausal 
women compared to postmenopaused 
(25% vs 10%). Early postmenopausal 
women demonstrated ET of <5mm, 
eventually reaching 2mm in those >70 
years old. A cut-off <5.0mm was 
considered clinically acceptable as normal 
postmenopausal ET regardless of ethnicity. 
With a gradual decline in OV with age and 
menopause from about 7cm3 at age 45-49 
years to less than 1.5cm3 at 70 years old, a 
clinical normal OV of <7.5 cm3 and <3.5cm3 
respectively was suggested for pre and 
postmenopausal Malaysian women. Benign 
ovarian cysts were found in 2.9%. 
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